ShockWave Medical, Inc. (SWAV)
NASDAQ: SWAV · IEX Real-Time Price · USD
174.33
5.66 (3.36%)
At close: May 27, 2022 4:00 PM
175.58
1.25 (0.72%)
After-hours:May 27, 2022 6:01 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Revenue | 237.15 | 67.79 | 42.93 | 12.26 | 1.72 |
| Revenue Growth (YoY) | 249.83% | 57.92% | 250.05% | 613.38% | - |
| Cost of Revenue | 41.44 | 20.99 | 17.16 | 7.25 | 2.84 |
| Gross Profit | 195.71 | 46.8 | 25.77 | 5.01 | -1.12 |
| Selling, General & Admin | 146.04 | 75.54 | 44.75 | 23.52 | 11.79 |
| Research & Development | 50.54 | 36.93 | 32.85 | 22.7 | 17.96 |
| Operating Expenses | 196.58 | 112.46 | 77.61 | 46.21 | 29.75 |
| Operating Income | -0.87 | -65.66 | -51.84 | -41.2 | -30.87 |
| Interest Expense / Income | 1.1 | 1.21 | 0.94 | 0.4 | 0.06 |
| Other Expense / Income | 6.87 | -1.26 | -1.74 | -0.54 | -0.33 |
| Pretax Income | -8.84 | -65.62 | -51.05 | -41.06 | -30.59 |
| Income Tax | 0.3 | 0.08 | 0.06 | 0.04 | 0.03 |
| Net Income | -9.14 | -65.7 | -51.11 | -41.1 | -30.62 |
| Net Income Common | -9.14 | -65.7 | -51.11 | -41.1 | -30.62 |
| Shares Outstanding (Basic) | 35 | 33 | 24 | 2 | 2 |
| Shares Outstanding (Diluted) | 35 | 33 | 24 | 2 | 2 |
| Shares Change | 6.07% | 38.42% | 1260.47% | 13.12% | - |
| EPS (Basic) | -0.26 | -1.99 | -2.14 | -23.39 | -19.71 |
| EPS (Diluted) | -0.26 | -1.99 | -2.14 | -23.39 | -19.71 |
| Free Cash Flow Per Share | 0.07 | -2.50 | -2.17 | -24.73 | -19.81 |
| Gross Margin | 82.53% | 69.03% | 60.03% | 40.88% | -64.98% |
| Operating Margin | -0.37% | -96.86% | -120.76% | -335.97% | -1795.52% |
| Profit Margin | -3.85% | -96.92% | -119.06% | -335.17% | -1780.98% |
| Free Cash Flow Margin | 1.10% | -122.00% | -120.96% | -354.29% | -1790.11% |
| Effective Tax Rate | -3.41% | -0.12% | -0.12% | -0.09% | -0.08% |
| EBITDA | -2.2 | -61.06 | -47.82 | -39.96 | -30.06 |
| EBITDA Margin | -0.93% | -90.08% | -111.40% | -325.88% | -1748.87% |
| EBIT | -7.74 | -64.41 | -50.1 | -40.66 | -30.53 |
| EBIT Margin | -3.26% | -95.01% | -116.72% | -331.59% | -1776.09% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).